FDA Inspection 1101585 — Pfizer Inc
The FDA completed an inspection of Pfizer Inc on August 20, 2019 in Chesterfield, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 20, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Chesterfield, MO (United States)